startingGLP.com is operated by Andros Health LLC d/b/a startingGLP. startingGLP provides technology, administrative, payment, laboratory-coordination, patient-support, and pharmacy-coordination services. startingGLP is not a medical practice, healthcare provider, pharmacy, health insurer, clinical laboratory, or drug manufacturer. startingGLP does not diagnose medical conditions, practice medicine, prescribe medication, compound medication, or dispense medication.
Medical services are provided independently by licensed healthcare professionals through Dr Telx LLC. Dr Telx clinicians exercise independent medical judgment and determine whether laboratory testing, additional evaluation, prescription treatment, referral, or another course of care is medically appropriate. Completing an online questionnaire, purchasing a startingGLP program, submitting a laboratory specimen, receiving laboratory results, or participating in a consultation does not guarantee a prescription or access to any particular medication.
When medically appropriate, legally permitted, and available, a Dr Telx clinician may prescribe an FDA-approved commercial medication, including medications such as Wegovy®, Zepbound®, Saxenda®, Ozempic®, Mounjaro®, Rybelsus®, Trulicity®, or another appropriate prescription treatment.
Some medications identified on this website are FDA-approved for chronic weight management. Other medications may be FDA-approved for conditions such as type 2 diabetes and may be prescribed for another use only when the treating clinician independently determines that such use is medically appropriate. Mention of a medication on this website does not mean that it is appropriate for you or that it will be prescribed, covered by insurance, available from a pharmacy, or offered at a particular price.
FDA-approved commercial medications are dispensed by appropriately licensed pharmacies and may be subject to patient eligibility requirements, insurance coverage, prior authorization, manufacturer restrictions, pharmacy participation, pricing, and supply availability.
When medically appropriate and lawfully permitted, a Dr Telx clinician may instead prescribe a patient-specific compounded medication prepared and dispensed by a licensed compounding pharmacy. Compounded medications may contain ingredients such as semaglutide or tirzepatide, but compounded formulations are distinct from FDA-approved branded medications.
Compounded medications are not FDA-approved. FDA does not review compounded medications for safety, effectiveness, quality, manufacturing consistency, or bioequivalence before they are marketed. Compounded medications are not FDA-approved generic versions of Wegovy®, Ozempic®, Zepbound®, Mounjaro®, or any other branded medication and should not be represented as the same as, equivalent to, or interchangeable with an FDA-approved product.
FDA states that compounded drugs may be appropriate for certain patients whose medical needs cannot be met by an available FDA-approved medication, but compounded drugs generally present greater risk because they do not undergo FDA premarket review for safety, effectiveness, or quality.
startingGLP is an independent platform and is not affiliated with, sponsored by, endorsed by, or associated with the manufacturers of any branded medication identified on this website. All product names and trademarks are the property of their respective owners.
Treatment decisions are based on the clinician’s independent review of the patient’s health history, current medications, allergies, symptoms, laboratory results where available, treatment goals, and other relevant clinical information. Laboratory results are one part of the clinical evaluation and cannot independently determine whether treatment is safe or appropriate.
Treatment is not appropriate for everyone. A consultation does not guarantee a prescription. Medication availability, eligibility, pricing, insurance coverage, treatment response, and individual results vary.